共 50 条
PLGA-based drug delivery system for combined therapy of cancer: research progress
被引:22
|作者:
Ruirui, Zhang
[1
]
He, Jian
[1
]
Xu, Ximei
[1
]
Li, Shengxian
[1
]
Peng, Hongmei
[2
]
Deng, Zhiming
[2
]
Huang, Yong
[1
,2
]
机构:
[1] Guangxi Med Univ, Collaborat Innovat Ctr Targeting Tumor Diag & The, Natl Ctr Int Res Biotargeting Theranost, Guangxi Key Lab Biotargeting Theranost, Nanning 530021, Peoples R China
[2] First Peoples Hosp Changde City, Changde, Peoples R China
关键词:
PLGA;
drug delivery;
tumor;
combination therapy;
micro;
nanoparticles;
POLY(LACTIC-CO-GLYCOLIC ACID) NANOPARTICLES;
TUMOR-ASSOCIATED MACROPHAGES;
ANTIGEN-PRESENTING CELLS;
TARGETED CO-DELIVERY;
COMPOSITE MICROPARTICLES;
RESPONSIVE NANOPARTICLES;
HYBRID NANOPARTICLES;
ANTITUMOR IMMUNITY;
CONTROLLED-RELEASE;
IN-VITRO;
D O I:
10.1088/2053-1591/ac3f5e
中图分类号:
T [工业技术];
学科分类号:
08 ;
摘要:
In recent years, PLGA micro/nano particle drug delivery systems has been widely used in cancer treatment. According to the unique properties of PLGA, carriers of various structures are designed to keep the function of drugs or bioactive substances, ensure the effective load of molecules and improve the bioavailability of drugs in diseased parts. PLGA is one of the earliest and most commonly used biodegradable materials. It is often used for functional modification with other polymers (such as polyethylene glycol and chitosan) or other molecules (such as aptamers and ligands) to deliver various small molecule drugs (such as DOX and DTX) and bioactive macromolecules (such as proteins and nucleic acids) to improve targeting, controlled release and therapeutic properties. In this paper, the preparation methods, physical and chemical properties and medical applications of PLGA micro/nano particles are discussed. We focused on the recent research progress of the PLGA-based drug carrier system in tumor combination therapy.
引用
收藏
页数:17
相关论文